Tumor characteristics in screen-detected and symptomatic breast cancers

被引:51
|
作者
Palka, Istvan [2 ]
Kelemen, Gyoengyi [1 ]
Ormandi, Katalin [3 ,6 ]
Lazar, Gyoergy [4 ]
Nyari, Tibor [5 ]
Thurzo, Laszlo [1 ]
Kahan, Zsuzsanna [1 ]
机构
[1] Univ Szeged, Dept Oncotherapy, H-6720 Szeged, Hungary
[2] Univ Szeged, Dept Pathol, H-6720 Szeged, Hungary
[3] Univ Szeged, Dept Radiol, H-6720 Szeged, Hungary
[4] Univ Szeged, Dept Surg, H-6720 Szeged, Hungary
[5] Univ Szeged, Dept Med Informat, H-6720 Szeged, Hungary
[6] Euromed Diagnost Szeged Ltd, Szeged, Hungary
关键词
adjuvant therapy; casting calcifications; mammographic screening; mammographic image; prognosis;
D O I
10.1007/s12253-008-9010-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The natural course of early breast cancer has changed as a result of the introduction of mammographic screening. The present aim was a prospective analysis of screen-detected and symptomatic operable breast cancers in the era of mammographic service screening. The mode of detection (screen-detected, symptomatic or interval cancer), the type of mammographic image and other characteristics (the invasive tumor size, histological tumor type, grade, nodal, hormone receptor and HER2 status and the presence of lymphovascular invasion) of 569 invasive breast cancers were studied. Screen-detected cancers were significantly more frequently of grade I, < 10 mm of size and node-negative (p< 0.001, respectively). Symptomatic/interval cancers were significantly more frequently of grade 3, > 20 mm of size (p< 0.001), and exhibited lymphovascular invasion (p= 0.001). Screening-detection of the tumor favored breast-conserving surgery, sentinel lymph node biopsy and the avoidance of chemotherapy (p< 0.001). Cancers associated with casting-type calcifications on the mammogram were typically of ductal type (p= 0.043), of grade 2 -3, estrogen receptor and progesterone receptor-negative and HER2-positive (p< 0.001). Interval cancers occurred significantly more often at a younger age and remained mammographically occult as compared with other cancers. Mammographic screen-detected cancers demonstrate more favorable prognostic features, and need less extensive treatment than symptomatic or interval cancers. The mammographic appearance of the tumor reflects its biological behavior, and this should be considered in the management optimization.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [1] Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
    Dawson, S. J.
    Duffy, S. W.
    Blows, F. M.
    Driver, K. E.
    Provenzano, E.
    LeQuesne, J.
    Greenberg, D. C.
    Pharoah, P.
    Caldas, C.
    Wishart, G. C.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1338 - 1344
  • [2] Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
    S J Dawson
    S W Duffy
    F M Blows
    K E Driver
    E Provenzano
    J LeQuesne
    D C Greenberg
    P Pharoah
    C Caldas
    G C Wishart
    [J]. British Journal of Cancer, 2009, 101 : 1338 - 1344
  • [3] Breast screening interval and the characteristics of screen-detected cancers
    Tupper, Carl A.
    Maxwell, Anthony J.
    Astley, Susan
    Bydder, Megan
    Gadde, Soujanya
    Harkness, Elaine
    Lim, Yit Y.
    Wilson, Mary
    Morris, Julie
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [4] Breast screening interval and the characteristics of screen-detected cancers
    Carl A Tupper
    Anthony J Maxwell
    Susan Astley
    Megan Bydder
    Soujanya Gadde
    Elaine Harkness
    Yit Y Lim
    Mary Wilson
    Julie Morris
    [J]. Breast Cancer Research, 17
  • [5] Biologic characteristics of interval and screen-detected breast cancers
    Gilliland, FD
    Joste, N
    Stauber, PM
    Hunt, WC
    Rosenberg, R
    Redlich, G
    Key, CR
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (09) : 743 - 749
  • [6] Interval breast cancers have worse tumor characteristics and survival compared to screen-detected breast cancers
    de Munck, L.
    Siesling, S.
    Pijnappel, R. M.
    van der Vegt, B.
    de Bock, G. H.
    [J]. CANCER RESEARCH, 2016, 76
  • [7] Explaining the difference in prognosis between screen-detected and symptomatic breast cancers
    P C Allgood
    S W Duffy
    O Kearins
    E O'Sullivan
    N Tappenden
    M G Wallis
    G Lawrence
    [J]. British Journal of Cancer, 2011, 104 : 1680 - 1685
  • [8] Explaining the difference in prognosis between screen-detected and symptomatic breast cancers
    Allgood, P. C.
    Duffy, S. W.
    Kearins, O.
    O'Sullivan, E.
    Tappenden, N.
    Wallis, M. G.
    Lawrence, G.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1680 - 1685
  • [9] AGGRESSIVENESS OF SCREEN-DETECTED BREAST CANCERS
    HAKAMA, M
    HOLLI, K
    ISOLA, J
    KALLIONIEMI, OP
    KARKKAINEN, A
    VISAKORPI, T
    PUKKALA, E
    SAARENMAA, I
    GEIGER, U
    IKKALA, J
    NIEMINEN, T
    GODENHJELM, K
    KOIVULA, T
    [J]. LANCET, 1995, 345 (8944): : 221 - 224
  • [10] Re: Biologic characteristics of interval and screen-detected breast cancers
    Eisinger, F
    Juliain-Reynier, C
    Sobol, H
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) : 1533 - 1534